Authors: Milligan, G Kellett, E Dacquet, C Dubreuil, V Jacoby, E Millan, MJ Lavielle, G Spedding, M

Citation: G. Milligan et al., S 14506: novel receptor coupling at 5-HT1A receptors, NEUROPHARM, 40(3), 2001, pp. 334-344

Authors: Cayatte, AJ Du, Y Oliver-Krasinski, J Lavielle, G Verbeuren, TJ Cohen, RA

Citation: Aj. Cayatte et al., The thromboxane receptor antagonist S18886 but not aspirin inhibits atherogenesis in apo E-deficient mice - Evidence that eicosanoids other than thromboxane contribute to atherosclerosis, ART THROM V, 20(7), 2000, pp. 1724-1728

Authors: Millan, MJ Gobert, A Newman-Tancredi, A Lejeune, F Cussac, D Rivet, JM Audinot, V Dubuffet, T Lavielle, G

Citation: Mj. Millan et al., S33084, a novel, potent, selective, and competitive antagonist at dopamineD-3-receptors: I. Receptorial, electrophysiological and neurochemical profile compared with GR218,231 and L741,626, J PHARM EXP, 293(3), 2000, pp. 1048-1062

Authors: Millan, MJ Dekeyne, A Rivet, JM Dubuffet, T Lavielle, G Brocco, M

Citation: Mj. Millan et al., S33084, a novel, potent, selective, and competitive antagonist at dopamineD-3-receptors: II. Functional and behavioral profile compared with GR218,231 and L741,626, J PHARM EXP, 293(3), 2000, pp. 1063-1073

Authors: Dubuffet, T Newman-Tancredi, A Cussac, D Audinot, V Loutz, A Millan, MJ Lavielle, G

Citation: T. Dubuffet et al., Novel benzopyrano[3,4-c]pyrrole derivatives as potent and selective dopamine D-3 receptor antagonists, BIOORG MED, 9(14), 1999, pp. 2059-2064

Authors: Dubuffet, T Loutz, A Lavielle, G

Citation: T. Dubuffet et al., An efficient large scale synthesis of coumarins by a dealkylative boron-mediated ring closure of 3-(orthomethoxyaryl)propenoic esters., SYN COMMUN, 29(6), 1999, pp. 929-936